Torthaí cuardaigh - Patrik Olekšák

  • 1 - 7 toradh as 7 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Rapamycin: Drug Repurposing in SARS-CoV-2 Infection

    Rapamycin: Drug Repurposing in SARS-CoV-2 Infection de réir Jiří Patočka, Kamil Kuča, Patrik Olekšák, Eugenie Nepovimová, Martin Vališ, Michal Novotný, Blanka Klímová

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Marine Invertebrate Peptides: Antimicrobial Peptides

    Marine Invertebrate Peptides: Antimicrobial Peptides de réir Ran Wu, Jiří Patočka, Eugenie Nepovimová, Patrik Olekšák, Martin Vališ, Wenda Wu, Kamil Kuča

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Novel CRISPR–Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives

    Novel CRISPR–Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives de réir Sweta Nidhi, Uttpal Anand, Patrik Olekšák, Pooja Tripathi, Jonathan A. Lal, George Thomas, Kamil Kuča, Vijay Tripathi

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Fentanyl and its derivatives: Pain-killers or man-killers?

    Fentanyl and its derivatives: Pain-killers or man-killers? de réir Jiří Patočka, Wenda Wu, Patrik Olekšák, Romana Jelínková, Eugenie Nepovimová, Lenka Spicanova, Pavlina Springerova, Suliman Yousef Alomar, Long Miao, Kamil Kuča

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Herbal drugs and natural bioactive products as potential therapeutics: A review on pro-cognitives and brain boosters perspectives

    Herbal drugs and natural bioactive products as potential therapeutics: A review on pro-cognitives and brain boosters perspectives de réir Swati Halder, Uttpal Anand, Samapika Nandy, Patrik Olekšák, Safaa Qusti, Eida M. Alshammari, Gaber El‐Saber Batiha, Eapen P. Koshy, Abhijit Dey

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Frentizole derivatives with mTOR inhibiting and senomorphic properties

    Frentizole derivatives with mTOR inhibiting and senomorphic properties de réir Žofia Chrienová, David Rysanek, Josef Novák, Pavla Vašicová, Patrik Olekšák, Rudolf Andrýs, Adam Skarka, J. Dumanović, Zoran Milovanović, Vesna Jaćević, Markéta Chvojková, Kristína Holubová, Karel Valeš, Veronika Skoupilova, Marián Valko, Klaudia Jomová, Suliman Yousef Alomar, Fernanda D. Botelho, Tanos C. C. França, Kamil Kuča, Zdeněk Hodný, Eugenie Nepovimová

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Erratum to “Frentizole derivatives with mTOR inhibiting and senomorphic properties” [Biomed. Pharmacother. 167 (2023) 115600]

    Erratum to “Frentizole derivatives with mTOR inhibiting and senomorphic properties” [Biomed. Pharmacother. 167 (2023) 115600] de réir Žofia Chrienová, David Rysanek, Josef Novák, Pavla Vašicová, Patrik Olekšák, Rudolf Andrýs, Adam Skarka, J. Dumanović, Zoran Milovanović, Vesna Jaćević, Markéta Chvojková, Kristína Holubová, Karel Valeš, Veronika Skoupilova, Marián Valko, Klaudia Jomová, Suliman Yousef Alomar, Fernanda D. Botelho, Tanos C. C. França, Kamil Kuča, Zdeněk Hodný, Eugenie Nepovimová

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Errata/Corrigenda
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: